Sunshine Biopharma (SBFM) Shares Outstanding (Weighted Average) (2010 - 2026)

Sunshine Biopharma has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 81.48% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 81.48% YoY), and the FY2025 full-year result was $4.2 million, up 492.39% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $4.9 million, up from $4.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $15.8 million in Q2 2022, with the low at $11914.0 in Q2 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $4.1 million across 5 years, with a median of $2.7 million in 2025.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) slumped 99.92% — and 2024, when it surged 10244.09%.
• Sunshine Biopharma's Shares Outstanding (Weighted Average) stood at $15.2 million in 2022, then plunged by 99.92% to $12825.0 in 2023, then soared by 5371.73% to $701749.0 in 2024, then soared by 492.39% to $4.2 million in 2025, then advanced by 18.01% to $4.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $4.9 million (Q1 2026), $4.2 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.